Active Ingredient(s): Fostamatinib
FDA Approved: * April 17, 2018
Pharm Company: * RIGEL PHARMS INC
Category: Immune System

Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia (ITP).[1][2] The drug is administered by mouth.[1][2] Fostamatinib blocks the activity of the enzyme spleen tyrosine kinase (SYK).[2] This enzyme is involved in stimulating parts of the immune system.[2] By blocking SYK's activity, fostamati... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Tavalisse 100 mg Oral Tablet
NDC: 71332-001
Rigel Pharmaceuticals, Inc.
Tavalisse 150 mg Oral Tablet
NDC: 71332-002
Rigel Pharmaceuticals, Inc.

Popular Topics

Tavalisse for low platelet count / chronic immune thrombocytopenia

A new drug by the name of Tavalisse (fostamatinib disodium hexahydrate) is reportedly being investigated for use in trea...